Table 2.
Antibody | Dilution | Standard | Specification | Source | Immunolocalisation |
---|---|---|---|---|---|
Anti‐CD31 | 1:1000 | ++ | SC‐1506 | Sta Cruz Biotech | Cytoplasm |
Anti‐VEGF | 1:50 | ++ | Clone VG1 | Neomarkers | Cytoplasm |
Statistically significant difference in the control group on days 14 and 28 (P = 0.001) and 14 and 35 days (P = 0.007).